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Mitochondrial energy production is involved in various cellular processes. Here we show that ATP
content is signiﬁcantly increased in lineage-restricted progenitor cells compared with hematopoi-
etic stem and progenitor cells (HSPCs) or more differentiated cells. Transplantation analysis using
a mouse model of mitochondrial disease revealed that mitochondrial respiration defects resulted
in a signiﬁcant decrease in the total number and repopulating activity of bone marrow cells,
although the number of HSPCs increased. The proliferative activity of HSPCs and lineage-restricted
progenitor cells was not impaired by reduction of ATP content and there seems to be no associated
increase in reactive oxygen species levels and apoptosis. Our ﬁndings indicate that mitochondrial
respiration defects modulate HSPC commitment/differentiation into lineage-restricted progenitor
cells.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Mitochondria are multi-functional organelles that play a vital
role in the cell, providing most of the cellular energy through oxi-
dative phosphorylation in the form of ATP and participating in Ca2+
homeostasis, cell death, and differentiation [1,2]. Mammalian cells
contain hundreds to thousands of mitochondria and each mito-
chondrion has multiple copies of mitochondrial DNA (mtDNA),
which replicates independently of the nuclear genome. The actual
number of mitochondria per cell varies depending on cell type and
energy demand. The mtDNA contains 22 tRNA genes, 2 rRNA genes,
and 13 structural genes encoding subunits of the respiratory chain
complexes. A high accumulation of mtDNA with pathogenic muta-
tions causes mitochondrial dysfunction, resulting in mitochondrial
diseases [3]. Mitochondrial diseases are characterized by a widechemical Societies. Published by E
genitor cells; HSCs, hemato-
; CLPs, common lymphoid
tDNA, mitochondrial DNA;
e oxygen species
ayashi), miyoshi@brc.riken.jpvariety of symptoms affecting many tissues, including myopathy,
cardiomyopathy, peripheral neuropathy, dementia. seizures, deaf-
ness, optic atrophy, and diabetes. A single large-scale mtDNA dele-
tion has been identiﬁed as the cause of Pearson’s syndrome [4], a
severe disorder of infancy characterized by sideroblastic anemia
with vacuolization of bone marrow (BM) precursor cells and exo-
crine pancreatic dysfunction [5], although BM failure is an uncom-
mon feature of mitochondrial diseases. Indeed, mitochondria are
implicated in hematopoietic cell homeostasis in various ways such
as heme biosynthesis and caspase activation in erythroid differen-
tiation [6–8]. However, it is still poorly understood whether mito-
chondrial energy production has an essential role in cell viability,
proliferation, and differentiation in the hematopoietic system.
We have previously reported the generation of a mouse model
of mitochondrial disease, called mito-mouse, carrying mtDNA with
a pathogenic 4696-bp deletion (DmtDNA) [9]. All tissue cells of
mito-mice have a mixture of DmtDNA and wild-type (WT) mtDNA
(i.e., heteroplasmy), and the proportion of DmtDNA usually in-
creases with aging [10]. Mito-mice with high loads of DmtDNA
show mitochondrial respiration defects in various tissues and
mitochondrial disease phenotypes including low body weight,
lactic acidosis, ischemia, myopathy, heart block, deafness, male
infertility, anemia, and renal failure [9,11–13]. However, expres-
sion of anemia could be due to chronic renal failure. We havelsevier B.V. All rights reserved.
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from mito-mice result in mild anemia by suppressing erythroid
differentiation [14]. In this study, we further evaluated the effects
of mitochondrial respiration defects on the hematopoietic system
using mito-mice.2. Materials and methods
2.1. Mice and BM transplantation
Mito-mice were generated as described previously [9]. B6-
Ly5.1/Ly5.2 F1 mice were obtained by mating pairs of B6-Ly5.1
(RIKEN BRC, Tsukuba, Japan) and B6-Ly5.2 mice (Charles River
Laboratories Japan, Yokohama, Japan). 1  106 BM cells from
mito-mice (Ly5.2) or B6-Ly5.2 mice were transplanted into leth-
ally (9.5 Gy) irradiated B6-Ly5.1 mice. The competitive repopula-
tion assay was performed as described previously [15]. For serial
BM transplantation, 1  106 BM cells isolated from recipient
mice at 12 weeks after transplantation were transplanted into
lethally irradiated B6-Ly5.1 mice. All animal experiments were
approved by the Animal Experiment Committee at the RIKEN
Tsukuba Institute.
2.2. Estimation of mtDNA proportions
The proportion of DmtDNA in hematopoietic cells was deter-
mined by quantitative real-time polymerase chain reaction (PCR)
analysis as described previously [10].
2.3. Measurement of ATP contents
The intracellular ATP content was determined by a luciferin–
luciferase assay using an ATP assay kit (TOYO B-Net, Tokyo, Japan)
according to the manufacturer’s instructions. The luminescent sig-
nals were detected with a Centro LB960 luminometer (Berthold
Technologies, Bad Wildbad, Germany).
2.4. Flow cytometry
For isolation of primitive hematopoietic cell populations, BM
cells were stained with a lineage marker antibody cocktail consist-
ing of biotinylated anti-Gr-1, anti-Mac-1, anti-B220, anti-IgM, anti-
CD4, anti-CD8, and anti-Ter119 antibodies, and subsequently
stained with ﬂuorescein isothiocyanate (FITC)-conjugated anti-
Sca-1, phycoerythrin (PE)-conjugated anti-IL-7Ra, and allophyco-
cyanin (APC)-conjugated anti-c-Kit antibodies. The biotinylated
antibodies were developed with streptavidin-APC-Cy7. For analy-
sis of BM and peripheral blood (PB) cells in transplanted mice,
the following antibodies were used: FITC-conjugated anti-Ly5.2,
anti-CD34, and anti-Sca-1, PE-conjugated anti-Ly5.1, anti-Sca-1,
and anti-IL-7Ra, APC-conjugated anti-B220, anti-CD4, anti-CD8,
and anti-c-Kit, PE-Cy7-conjugated anti-B220, anti-Mac-1, and
anti-Gr-1, biotinylated anti-lineage markers, streptavidin-PerCP,
strreptavidin-APC-Cy7 (all antibodies from eBioscience, San Diego,
CA). The stained cells were analyzed with a FACSCalibur and sorted
with a FACSVantage SE or a FACSAria (BD Biosciences, San Jose, CA).
For cell cycle analysis, sorted cells were ﬁxed in 70% ethanol
overnight and stained with propidium iodide (PI). For Ki-67 stain-
ing, sorted cells were incubated in PBS containing 1% formaldehyde
for 30 min at 4 C, followed by addition of an equal volume of PBS
containing 0.2% Triton X-100, and stored overnight at 4 C. The
cells were then washed with PBS and stained with FITC-conjugated
anti-human Ki-67 monoclonal antibody (BD Biosciences) for
30 min, followed by staining with 5 lg/ml 7-aminoactinomycin-
D (7-AAD) (Sigma–Aldrich, St Louis, MO).For analysis of intracellular reactive oxygen species (ROS) levels,
sorted cells were incubated with 10 lM 20,70-dichloroﬂuorescin
diacetate (DCF-DA) (Invitrogen, Carlsbad, CA) for 10 min at 37 C.
For apoptosis analysis, sorted cells were stained with FITC-con-
jugated Annexin V (BD Biosciences) for 15 min at room tempera-
ture, followed by staining with 5 lg/ml 7-AAD.
2.5. CFC assay
2  105 BM cells isolated from transplanted mice were plated
into MethoCult GF M3434 (StemCell Technologies, Vancouver,
Canada). After 2 weeks of incubation, the number of colonies (col-
ony diameter >1 mm) was counted under a microscope.
2.6. Statistical analysis
Data were analyzed with an unpaired Student’s t-test. All values
are means ± S.D., and values with P < 0.05 were considered
signiﬁcant.3. Results
3.1. ATP content is signiﬁcantly increased in lineage-restricted
progenitor cells
Hematopoietic stem cells (HSCs) reside in the adult BM and give
rise to all blood cells throughout life with the capacity for self-re-
newal and multilineage differentiation. HSCs generate multipotent
progenitors (MPPs) that lose the ability to self-renew and give rise
to two lineage-restricted progenitors, common lymphoid progeni-
tors (CLPs) and commonmyeloid progenitors (CMPs) that are capa-
ble of differentiating into lymphocytes and myeloerythroid cells,
respectively [16,17]. To understand and evaluate the role of mito-
chondria during hematopoiesis, we ﬁrst measured ATP content of
hematopoietic stem and progenitor cells (HSPCs) (i.e., HSCs and
MPPs), CMPs, CLPs, and differentiated mature (Lin+) cells isolated
from the BM of B6 mice (Fig. 1A and B). The results showed that
ATP content is signiﬁcantly higher in CMPs and CLPs than in HSPCs
and differentiated cells (Fig. 1C). Cell cycle analysis indicated an in-
creased cycling activity in CMPs and CLPs as expected (Fig. 1D).
These results suggest that mitochondrial energy production tran-
siently increase after MPP stage, and the proliferative activity
and/or commitment ability are associated with their energy status.
3.2. Effects of mitochondrial respiration defects on hematopoiesis
In our previous studies, we demonstrated that ATP content of
BM cells in mito-mice carrying 7783% DmtDNA was signiﬁcantly
decreased as compared with WT mice [14]. WT B6-Ly5.1 mice
transplanted with BM cells from mito-mice carrying 8182%
DmtDNA (B6/BMDmtDNA mice) showed abnormalities in erythroid
differentiation [14]. To further characterize the hematopoietic
cell-speciﬁc effect of mitochondrial respiration defects, we ana-
lyzed the total number of BM and differentiated cells in B6/
BMDmtDNA mice in which donor BM cells carried >75% DmtDNA.
The results showed that the number of BM cells in femur and tibia
decreased by 24% as compared with B6-Ly5.1 mice transplanted
with BM cells from control B6-Ly5.2 mice (B6/BMWT mice)
(Fig. 2A). Interestingly, the number of B lymphoid cells, but not T
lymphoid and myeloid cells, decreased dominantly (Fig. 2B). In vi-
tro colony-forming cell (CFC) assay showed that the CFC frequency
of BM cells from B6/BMDmtDNA mice decreased markedly (Fig. 2C).
These results together with our previous observations suggest that
donor BM cells carrying a high proportion of DmtDNA could not
completely repopulate in BM cells of B6/BMDmtDNA mice, and ter-
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Fig. 1. ATP contents and cell cycle status of BM cells in WT B6mice. (A) The primitive hematopoietic hierarchy is shown. (B) Representative ﬂuorescence-activated cell sorting
(FACS) proﬁles of BM cells showing HSPCs (Lin, c-Kit+, and Sca-1+), CMPs (Lin, c-Kit+, and Sca-1), CLPs (Lin, c-Kitlow, Sca-1low, and IL-7Ra+), and differentiated mature cells
(Lin+). The numbers indicate the percentage of gated subpopulations. (C) HSPCs, CMPs, CLPs, and Lin+ cells (730  103 cells/experiment) were isolated from the BM of B6
mice and ATP contents were measured by a luciferin–luciferase assay. Fold change relative to HSPCs is shown. The data represent the mean ± S.D. (n = 36). (D) Cell cycle
analysis of each cell population by PI staining. Representative FACS histograms showing DNA content and percentage of cells in the S/G2/M phases are shown. The data
represent the mean ± S.D. (n = 36). Asterisks indicate signiﬁcant differences (P < 0.05).
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require more energy than other differentiation pathways.We next analyzed the number and proportion of primitive
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Fig. 2. Effects of mitochondrial respiration defects on hematopoiesis in B6/
BMDmtDNA mice. (A) The total number of BM cells in left femur and tibia of B6/
BMDmtDNA (donor BM carried >75% DmtDNA) and B6/BMWT mice was counted
(n = 7). (B) Fold change in the number of each BM cell population in B6/BMDmtDNA
relative to B6/BMWT mice is shown (n = 7). (C) The number of CFCs per 2  105 BM
cells is shown (n = 3). The data represent the mean ± S.D. Asterisks indicate
signiﬁcant differences (P < 0.05).
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HSCs, MPPs, CMPs, and CLPs than those from B6/BMWT mice
(Fig. 3A). The numbers of CMPs and CLPs increased about 2- and
1.5-fold, respectively. Primitive cell populations, HSCs and MPPs,
increased more than 2.5- to 3.5-fold (Fig. 3B). ATP contents were
signiﬁcantly decreased in HSPCs and CMPs from B6/BMDmtDNAmice (Fig. 3C). Cell cycle analysis revealed that HSPCs from B6/
BMDmtDNA mice contained a slightly increased proportion of cells
in the S/G2/M phases of the cell cycle compared with those from
B6/BMWT mice although there was not much difference in CMPs
(Fig. 3D). Similar results were obtained by staining with anti-
Ki67 antibody (Fig. 3E). These results indicate that the proliferative
activity of primitive hematopoietic cells in the steady state is not
impaired by reduction of ATP content. Therefore, higher ATP con-
tents of CMPs and CLPs as shown in Fig. 1C are not likely to be
due to a requirement of a large amount of energy for proliferation.
3.3. Accumulation of HSPCs in mito-mice with a high proportion of
DmtDNA
To identify which hematopoietic stages are sensitive to the
reduction of mitochondrial energy production, we analyzed BM
cells in mito-mice carrying various proportions of DmtDNA. The
frequency of HSPCs gradually increased in BM cells with a medium
to high proportion of DmtDNA (Supplementary Fig. 1). In contrast,
CMPs and differentiated myeloid and lymphoid cells did not accu-
mulate much even with a high proportion of DmtDNA. These re-
sults suggest that mitochondrial energy production is required
primarily for commitment/differentiation of HSPCs and that
chronic stress of lower ATP contents results in accumulation of
HSPCs. Intriguingly, there was no mito-mice with BM cells carrying
>85% DmtDNA, although proportion of DmtDNA increased pro-
gressively with aging and other tissues possessed >85% DmtDNA.
It is possible that damaged mitochondria containing a high propor-
tion of DmtDNA in hematopoietic cells are selectively eliminated
by a catabolic process such as mitophagy.
3.4. Mitochondrial respiration defects impair repopulating activity of
HSCs
To examine the effects of mitochondrial respiration defects on
HSC function, an in vivo competitive repopulation assay was per-
formed. Test BM cells frommito-mice or B6-Ly5.2 mice were trans-
planted into lethally irradiated B6-Ly5.1 mice together with
competitor BM cells from B6-Ly5.1/5.2 F1 mice. At various times
after transplantation, PB chimerism was analyzed. The results
showed that the repopulating activity of BM cells frommito-mouse
carrying 82% DmtDNA was approximately half of that from control
mice onemonth after transplantation and declined over subsequent
months (Fig. 4A). Similar results were obtained by competitive
repopulation assay of puriﬁed HSCs (data not shown). We further
analyzed the proportion of test cell-derived cells in various cell pop-
ulationsof BMandPB. Inmice transplantedwithBMcells frommito-
mouse carrying 70% DmtDNA, the proportion of test cell-derived
cells was higher in HSPCs, CMPs, and CLPs of BM and was lower in
myeloid, T lymphoid, and B lymphoid cells of BM and PB (Fig. 4B),
consistent with the observations of B6/BMDmtDNA mice (Figs. 2A, B
and 3A, B). This is probably because differentiation but not prolifer-
ation of HSPCs and lineage-restricted progenitors was impaired by
mitochondrial respiration defects. The repopulating activity was
also assessed by serial BM transplantation. The tertiary recipients
that were transplanted with BM cells from mito-mice showed a
markedly reduced survival compared with the control group
(Fig. 4C). Overall, our results clearly indicate thatmitochondrial res-
piration defects result in a decline in the repopulating potential of
HSCs and accumulation of primitive hematopoietic cell populations.
3.5. Mitochondrial respiration defects by DmtDNA does not increase
ROS levels and apoptosis
Mitochondrial respiration defects increase oxidative stress and
stimulate apoptosis [18,19]. We therefore examined the intracellu-
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mice. DCF-DA, a ﬂuorescent ROS indicator, staining analysis re-
vealed no increase in ROS levels as compared with control B6/
BMWT mice (Supplementary Fig. 2A). Apoptosis analysis by Annex-
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apoptotic cells (Supplementary Fig. 2B). These results suggest that
impairment of primitive hematopoietic cells caused by mitochon-
drial respiration defects is not due to an increase in ROS production
or induction of apoptosis. Our previous study showed that high
accumulation of DmtDNA signiﬁcantly reduced activities of com-
plex I + III and IV in BM cells because of a large-scale deletion in
mtDNA, whereas activity of complex II, all encoded by nucleargenes, was increased [14]. It is possible that ROS production may
not be increased by DmtDNA.
3.6. Effects of mitochondrial respiration defects on lineage-speciﬁc
gene expression
We next analyzed expression levels of several lineage-speciﬁc
genes in HSPCs from B6/BMDmtDNA and B6/BMWT mice (Supple-
3408 S.-I. Inoue et al. / FEBS Letters 584 (2010) 3402–3409mentary Fig. 3). The expression of myeloperoxidase and macro-
phage colony-stimulating factor receptor, myeloid-speciﬁc genes
[20,21], was signiﬁcantly down-regulated in HSPCs from B6/
BMDmtDNA. In addition, among lymphoid-speciﬁc genes [22],
Notch-1 was down-regulated whereas GATA-3 was up-regulated.
It is conceivable that decreased intracellular ATP levels in HSPCs
may modulate expression of some genes that are associated with
commitment/differentiation, leading to accumulation of primitive
hematopoietic cells. Although the peroxisome proliferator-acti-
vated receptor-c coactivator 1a (PGC-1a) is known to be a domi-
nant regulator of mitochondrial biogenesis and oxidative
metabolism in many tissues [23], we did not observe a change in
the expression level of PGC-1a gene between HSCs and lineage-re-
stricted progenitors in WT mice (data not shown).
4. Discussion
It is well known that HSCs are usually in a quiescent state and
contain low numbers of mitochondria. It has been suggested that
glycolysis is a major source of ATP in HSCs. In contrast, the rap-
idly growing progenitor cells were thought to have increased
mitochondrial energy production due to their high proliferative
activity. In the present study, the use of mito-mice in BM trans-
plantation analysis allowed us to characterize the hematopoietic
cell-speciﬁc effect of mitochondrial respiration defects. Mitochon-
drial respiration defects resulted in accumulation of HSPCs with
decreased repopulating activity. However, the proliferative activ-
ity of HSPCs as well as lineage-restricted progenitors was not im-
paired. Our results suggest that differentiation from HSPCs to
lineage-restricted progenitors is a high-energy demand process,
given that ATP content is signiﬁcantly increased in CLPs and
CMPs.
A number of recent studies have provided evidence for a link
between intracellular ROS levels and preservation of stem cell
function. For instance, HSCs from ATM- or FoxO-deﬁcient mice
showed a reduced repopulating activity that was associated with
increased ROS levels [24–27]. The increase in ROS production ap-
pears to stimulate quiescent HSCs to enter the cell cycle through
activation of the p38 MAPK pathway, resulting in exhaustion of
the HSC pool. However, this may not be the case with mito-mice,
in which the intracellular ROS levels in HSPCs were not increased.
Recently, mitochondrial biogenesis during differentiation of
embryonic stem cells (ESCs) has been studied in detail [28]. Undif-
ferentiated ESCs contain low numbers of mitochondria located
around the nucleus and have low oxygen consumption. Upon dif-
ferentiation, the numbers of mitochondria increase and oxidative
phosphorylation is activated in order to promote the synthesis of
increased levels of ATP and the maintenance of differentiated cell
homeostasis [29–32]. These properties seem to be conserved be-
tween ESCs and HSCs [33]. Mitochondrial biogenesis and energy
production might therefore play an important role in early events
of stem cell differentiation.
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